[Clinical study of a drug combination in the treatment of metarheumatic and metatraumatic disorders].
D000328:Adult; D001591:Benzydamine / Q000627:therapeutic use*; D003288:Contusions / Q000188:drug therapy; D003992:Dibucaine / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010489:Periarthritis / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013180:Sprains and Strains / Q000188:drug therapy*; D014103:Torticollis / Q000188:drug therapy
D004338:Drug Combinations; D010880:Piperidines; D011720:Pyrazoles; D001591:Benzydamine; C009185:pridinol; D006821:Hyaluronoglucosaminidase; D003992:Dibucaine
Studio clinico di un preparato di associazione nella terapia delle forme metareumatiche e metatraumatiche.